---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-082245"
form_type: "8-K"
ticker: "FRMM"
cik: "0001690080"
company_name: "FORUM MARKETS Inc"
filed_at: "2022-12-22T23:59:59+00:00"
generated_at: "2026-06-21T00:07:47.236649+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# 180 Life Sciences raises ~$6M in registered direct offering of shares and warrants

## Summary
- Gross proceeds ~$6M from 1,714,286 shares (or equivalents) and warrants for 2,571,429 shares at $3.50/unit.
- Net proceeds ~$5.5M after fees; use includes R&D, marketing authorization for Dupuytren's contracture in UK.
- Warrants exercisable at $3.50/share starting 6 months after issuance, expiring 5 years from exercise date.
- Directors and executive officers subject to 90-day lock-up on company securities post-closing.
- A.G.P./Alliance Global Partners acted as sole placement agent for the offering.

## SEC filing metadata
- accession: 0001213900-22-082245
- form_type: 8-K
- ticker: FRMM
- cik: 0001690080
- company_name: FORUM MARKETS Inc
- filed_at: 2022-12-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1690080/000121390022082245/0001213900-22-082245-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1690080/000121390022082245/ea170740-8k_180lifesci.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-082245
- JSON: https://secwatch.observer/filing/0001213900-22-082245.json
- Plain text: https://secwatch.observer/filing/0001213900-22-082245.txt

## Key facts
- Material Agreements
  FORUM MARKETS Inc entered into Purchase Agreement with a certain institutional investor valued at approximately $6 million (effective 2022-12-20).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: a certain institutional investor
  - Value: approximately $6 million
  - Effective: 2022-12-20
  source text: On December 20, 2022, 180 Life Sciences Corp., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement (the “ Purchase Agreement ”) with a certain institutional investor (the “ Purchaser ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390022082245/0001213900-22-082245-index.htm
- Material Agreements
  FORUM MARKETS Inc entered into Warrant Agent Agreement with Continental Stock Transfer & Trust Company (effective 2022-12-22).
  - Action: entry
  - Counterparty: Continental Stock Transfer & Trust Company
  - Effective: 2022-12-22
  source text: On December 22, 2022, in connection with the closing of the offering, the Company entered into a Warrant Agent Agreement with Continental Stock Transfer & Trust Company, as warrant agent, in connection with each of the Pre-Funded Warrants and the Common Warrants (each, a “ Warrant Agent Agreement ” and, collectively, the “ Warrant Agent Agreements ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390022082245/0001213900-22-082245-index.htm
- Material Agreements
  FORUM MARKETS Inc entered into Placement Agent Agreement with A.G.P./Alliance Global Partners (effective 2022-12-20).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: A.G.P./Alliance Global Partners
  - Effective: 2022-12-20
  source text: On December 20, 2022, the Company also entered into a placement agent agreement (the “ Placement Agent Agreement ”) with A.G.P./Alliance Global Partners (the “ Placement Agent ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1690080/000121390022082245/0001213900-22-082245-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.